{{Rsnum
|rsid=13385191
|Gene=C2orf43
|Chromosome=2
|position=20688505
|Orientation=plus
|GMAF=0.2663
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=C2orf43
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 64.6 | 30.1 | 5.3
| HCB | 27.7 | 51.8 | 20.4
| JPT | 15.9 | 46.9 | 37.2
| YRI | 100.0 | 0.0 | 0.0
| ASW | 87.7 | 12.3 | 0.0
| CHB | 27.7 | 51.8 | 20.4
| CHD | 32.4 | 46.3 | 21.3
| GIH | 37.6 | 44.6 | 17.8
| LWK | 98.2 | 1.8 | 0.0
| MEX | 50.0 | 46.6 | 3.4
| MKK | 75.6 | 23.7 | 0.6
| TSI | 51.0 | 44.1 | 4.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20676098
|Trait=None
|Title=Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population
|RiskAllele=G
|Pval=8E-8
|OR=1.15
|ORtxt=[1.10-1.21]
}}

{{PMID Auto
|PMID=22056501
|Title=Replication of five prostate cancer loci identified in an Asian population - Results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3)
|OA=1
}}

{{PMID Auto
|PMID=22662242
|Title=Replication and fine mapping for association of the C2orf43, FOXP4, GPRC6A and RFX6 genes with prostate cancer in the Chinese population
|OA=1
}}

{{PMID Auto
|PMID=24411283
|Title=Prostate Cancer (PCa) Risk Variants and Risk of Fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}